Walleye Capital LLC

Position in CYTK — Cytokinetics Inc

CIK 1758720 NEW YORK, NY

Back to CYTK Full portfolio

Position in CYTK

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$20,422,428

+$20,422,428 QoQ

Shares Held

239,728

Ownership

0.172%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#88

of 473 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Jun 30, 2026

CallValue

$1,235,255

CallShares

14,500

PutValue

$1,482,306

PutShares

17,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,313,978 across 124 Biotechnology names. CYTK ranks #2 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	126,005	$33,608,053
2	CYTK	Cytokinetics Inc This page	239,728	$20,422,428
3	BMRN	Biomarin Pharmaceutical Inc	288,233	$16,492,692
4	IDYA	IDEAYA Biosciences, Inc.	386,183	$14,393,040
5	REGN	Regeneron Pharmaceuticals, Inc.	22,596	$14,089,509
6	RARE	Ultragenyx Pharmaceutical Inc.	334,854	$11,180,775
7	TYRA	Tyra Biosciences, Inc.	347,898	$11,111,862
8	BCAX	Bicara Therapeutics Inc.	353,226	$10,487,279

All Filings in CYTK

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,422,428	239,728	+1484.4%	Shares	Sole	2026-08-03
2026-06-30	$1,482,306	17,400	+70.6%	Put	Sole	2026-08-03
2026-06-30	$1,235,255	14,500	-44.0%	Call	Sole	2026-08-03
2026-03-31	$1,707,069	25,900	-4.1%	Call	Sole	2026-05-13
2026-03-31	$672,282	10,200	-42.0%	Put	Sole	2026-05-13
2025-12-31	$1,118,304	17,600	-61.1%	Put	Sole	2026-02-13
2025-12-31	$961,423	15,131	+260.0%	Shares	Sole	2026-02-13
2025-12-31	$1,715,580	27,000	+31.7%	Call	Sole	2026-02-13
2025-09-30	$2,489,688	45,300	-62.1%	Put	Sole	2025-11-14
2025-09-30	$1,126,680	20,500	-75.9%	Call	Sole	2025-11-14
2025-09-30	$230,996	4,203	-70.3%	Shares	Sole	2025-11-14
2025-06-30	$3,948,280	119,500	+16971.4%	Put	Sole	2025-08-13
2025-06-30	$2,811,704	85,100	+319.2%	Call	Sole	2025-08-13
2025-03-31	$28,133	700	-70.8%	Put	Sole	2025-05-14
2025-03-31	$815,857	20,300	+78.1%	Call	Sole	2025-05-14
2025-03-31	$567,884	14,130	-86.6%	Shares	Sole	2025-05-14
2024-06-30	$617,652	11,400	-79.6%	Call	Sole	2024-08-14
2024-06-30	$130,032	2,400	-90.2%	Put	Sole	2024-08-14
2024-03-31	$7,407,962	105,662	+180.5%	Shares	Sole	2024-05-15
2024-03-31	$3,912,138	55,800	+3620.0%	Call	Sole	2024-05-15
2024-03-31	$1,724,706	24,600	+34.4%	Put	Sole	2024-05-15
2023-12-31	$1,527,867	18,300	+103.3%	Put	Sole	2024-02-14
2023-12-31	$3,144,483	37,663	+48.7%	Shares	Sole	2024-02-14
2023-12-31	$125,235	1,500	-92.3%	Call	Sole	2024-02-14
2023-09-30	$265,140	9,000	-73.8%	Put	Sole	2023-11-21
2023-09-30	$577,416	19,600	-0.5%	Call	Sole	2023-11-21
2023-06-30	$642,614	19,700	+1131.2%	Call	Sole	2023-08-14
2023-06-30	$1,118,866	34,300	+629.8%	Put	Sole	2023-08-14
2023-06-30	$826,036	25,323	-88.2%	Shares	Sole	2023-08-14
2022-12-31	$215,354	4,700	+422.2%	Put	Sole	2023-02-14
2022-12-31	$73,312	1,600	+166.7%	Call	Sole	2023-02-14
2022-12-31	$9,814,827	214,204	+86.8%	Shares	Sole	2023-02-14
2022-09-30	$5,554,501	114,644	+35.1%	Shares	Sole	2022-11-14
2022-09-30	$43,605	900	-10.0%	Put	Sole	2022-11-14
2022-09-30	$29,070	600	-72.7%	Call	Sole	2022-11-14
2022-06-30	$3,334,149	84,860	+8.4%	Shares	Sole	2022-08-19
2022-03-31	$2,881,486	78,280	+148.4%	Shares	Sole	2022-05-27
2020-03-31	$11,790	1,000	—	Put	Sole	2020-05-15
2020-03-31	$371,561	31,515	—	Shares	Sole	2020-05-15
2020-03-31	$25,938	2,200	—	Call	Sole	2020-05-15
No filing history on record for this holder in this stock.